Joel B. Braunstein

About

Joel B. Braunstein, MD, MBA is the co-founder and CEO of C2N Diagnostics, a St. Louis diagnostics company focused on blood-based testing for Alzheimer's disease and related neurodegenerative conditions. His background includes internal medicine and cardiology training at Harvard and Johns Hopkins, an MBA with health policy focus, and a prior assistant professorship in cardiology at Johns Hopkins. Public disclosures also show he is an employee/shareholder of C2N and active in the broader brain-health diagnostics ecosystem.

Areas of interest